Rhythmical Massage Compared With Heart Rate Variability Biofeedback in Women With Menstrual Pain (Dysmenorrhea)

Efficacy of Rhythmical Massage in Comparison to Heart Rate Variability Biofeedback in Women With Primary Dysmenorrhea - a Randomized, Controlled Trial

A study to explore whether rhythmical massage and heart rate variability biofeedback can help to reduce pain in women suffering from menstrual pain (dysmenorrhea).

Study Overview

Status

Completed

Detailed Description

This is a three-arm randomized controlled trial to evaluate the efficacy of rhythmical massage and HRV biofeedback in women with primary dysmenorrhea compared to a control group. The main focus is on pain intensity during menstruation. Moreover, analgesics intake, SF-12 mental and physical scores and parameters of a 24h-HRV measurement are assessed before and after the three-month intervention.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Baden-Württemberg
      • Filderstadt, Baden-Württemberg, Germany, 70794
        • Die Filderklinik

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 46 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • At least one year of primary dysmenorrhea (physician-confirmed).
  • Written informed consent (also from parents/legal guardians of underage girls).
  • Menarche at least one year ago.

Exclusion Criteria:

  • Secondary dysmenorrhea.
  • Participation in another study.
  • Mental retardation.
  • Addiction.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Rhythmical massage
Participants who receive rhythmical massage for three months.
Rhythmical Massage according to Dr Ita Wegman, derived from Swedish Massage in the 1920s. Applied for various indications in the context of Anthroposophic Medicine, aiming at a recovery of self-regulation and self-healing forces.
EXPERIMENTAL: HRV biofeedback
Participants who perform HRV biofeedback for three months.
One of various biofeedback types, HRV biofeedback gives a visual feedback of the participant's heart rate variability as an indicator for general health, physical and cognitive performance, self-regulation and a decreased risk of illness.
NO_INTERVENTION: Control group
Participants who do not receive an intervention during the three-month intervention period but are advised to stay with their usual care during menstrual pain. For ethical and compliance reasons, these participants receive a series of rhythmical massage treatments after the initial three-month intervention/control period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean pain intensity during menstruation
Time Frame: Baseline (pre intervention) and after three months (post intervention).
Mean pain intensity on the three days of maximal menstrual discomfort, as indicated by the participants on a numeric rating scale in a pain diary.
Baseline (pre intervention) and after three months (post intervention).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum pain intensity during menstruation
Time Frame: Baseline (pre intervention) and after three months (post intervention).
Maximum pain intensity on the three days of maximal menstrual discomfort, as indicated by the participants on a numeric rating scale in a pain diary.
Baseline (pre intervention) and after three months (post intervention).
SF-12 sum-score
Time Frame: Baseline (pre intervention) and after three months (post intervention).
Overall quality of life as assessed by the SF-12 questionnaire.
Baseline (pre intervention) and after three months (post intervention).
SF-12 mental
Time Frame: Baseline (pre intervention) and after three months (post intervention).
Quality of life (subscore mental) as assessed by the SF-12 questionnaire.
Baseline (pre intervention) and after three months (post intervention).
SF-12 physical
Time Frame: Baseline (pre intervention) and after three months (post intervention).
Quality of life (subscore physical) as assessed by the SF-12 questionnaire.
Baseline (pre intervention) and after three months (post intervention).
SDNN
Time Frame: Baseline (pre intervention) and after three months (post intervention).
Standard deviation of normal to normal beats, derived from 24h ECGs.
Baseline (pre intervention) and after three months (post intervention).
RMSSD
Time Frame: Baseline (pre intervention) and after three months (post intervention).
Root mean square of successive differences, derived from 24h ECGs.
Baseline (pre intervention) and after three months (post intervention).
LF/HF-Ratio
Time Frame: Baseline (pre intervention) and after three months (post intervention).
LF/HF-Ratio = Ratio of two bands from frequency domain analysis: LF band (0.04-0.15 Hz), HF band (0.15-0.40 Hz), derived from 24h ECGs.
Baseline (pre intervention) and after three months (post intervention).
Analgesics intake during menstruation
Time Frame: Baseline (pre intervention) and after three months (post intervention).
Percentage of participants taking analgesics.
Baseline (pre intervention) and after three months (post intervention).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jan Vagedes, MD, Dr, Arcim Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 1, 2012

Primary Completion (ACTUAL)

March 1, 2014

Study Completion (ACTUAL)

March 1, 2014

Study Registration Dates

First Submitted

October 18, 2018

First Submitted That Met QC Criteria

October 18, 2018

First Posted (ACTUAL)

October 19, 2018

Study Record Updates

Last Update Posted (ACTUAL)

October 19, 2018

Last Update Submitted That Met QC Criteria

October 18, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Dysmenorrhea

Clinical Trials on Rhythmical massage

Subscribe